Cardiac Death due to Cardiomyophaties in Forensic Autopsies

Authors

  • Ferah Karayel Adli Tıp Kurumu Başkanlığı Morg İhtisas Dairesi
  • Arzu Akçay Turan Adli Tıp Kurumu Başkanlığı Morg İhtisas Dairesi
  • Işıl Pakiş Adli Tıp Kurumu Başkanlığı Morg İhtisas Dairesi
  • Elif Ülker Akyıldız Adli Tıp Kurumu Başkanlığı Morg İhtisas Dairesi
  • Gökhan Ersoy Adli Tıp Kurumu Başkanlığı Morg İhtisas Dairesi
  • Eyüp Yılmaz Adli Tıp Kurumu Başkanlığı Morg İhtisas Dairesi

DOI:

https://doi.org/10.17986/blm.2006112608

Keywords:

autopsy, cardiac sudden death, cardiomyopathy

Abstract

Cardiomyopathy is a group of myocardial muscle disease of unknown origin. Primary ones consist of dilated, hypertrophic, obliterative and ARVC subgroups. The aim of this study is to describe macroscopic and microscopic features of this pathologic entity that is a rare cause of death among young adult population. Eleven cases of cardiomyopathy were detected in autopsy population of the Council of Forensic Medicine between 2003 and 2006. Of these cases, 5 were male and 6 were female and age range was 15-35. After histopathologic examination of these cardiomyopathy cases, seven were detected to be hypertrophic, three dilated and one restrictive cardiomyopathy resulting from amyloid accumulation. No toxic substances were detected on routine toxicological analysis. The cause of death in these 11 sudden death cases was reported to be cardiac death resulting from cardiomyopathy. In order to support the legal investigation process in sudden deaths, it is crucial to establish the cause of death. Detailed macroscopic and microscopic examination of heart must be performed in order to detect cardiomyopathies during investigating the sudden death of young adults.

Key words: Autopsy, cardiac sudden death, cardiomyopathy

Downloads

Download data is not yet available.

References

Sheppard M, Davies MJ. Cardiac hypertrophy,myo- carditis and cardiomyopathy in Practical Cardiovascular Pathology lst.ed.Oxford University Pres. 1998: 103-148.

Silver MD, Gotlieb AI, Schoen FJ. Cardiomyopathies in Cardiovascular Pathology 3 rd edition. Churchill Livingstone Philadelphia, Pennsylvania. 2001; 285-325.

Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997;350:127-33. DOI: https://doi.org/10.1016/S0140-6736(97)01282-8

Maron BJ, Casey SA, Almquist AK. Extreme hypertrophic cardiomyopathy. Heart 2004;90(1):24. DOI: https://doi.org/10.1136/heart.90.1.24

Pakiş I, Turan AA, Karayel F, Üzün İ. Hipertrofik kardiyomiyopatiye bağlı ani ölüm olgusu. Adli Tıp Derg 2004;18(3-4):13-15.

Ng Belinda, Connors LH, Davidoff R. Senile systemic amyloidosis presenting with heart failure. Arch Intern Med 2005;165:1425-29. DOI: https://doi.org/10.1001/archinte.165.12.1425

Johansson B,Westermark P. Senile systemic amyloidosis: A clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991;32:83-92. DOI: https://doi.org/10.1016/0167-5273(91)90047-S

Downloads

Published

2006-08-01

Issue

Section

Research Article

How to Cite

1.
Karayel F, Turan AA, Pakiş I, Akyıldız E Ülker, Ersoy G, Yılmaz E. Cardiac Death due to Cardiomyophaties in Forensic Autopsies. Bull Leg Med. 2006;11(2):59-63. https://doi.org/10.17986/blm.2006112608